Publication|Articles|August 21, 2025
- Pharmaceutical Executive: August 2025
- Volume 45
- Issue 6
Pharmaceutical Executive: August 2025 Interactive Digital Edition
View the Pharmaceutical Executive August 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
4 months ago
The CAR-T Climb4 months ago
2025 Emerging Pharma Leaders4 months ago
An RNA-Guided Path4 months ago
Acceleration and Ambition4 months ago
Driving Disruption in Delivery4 months ago
Building Promise from Precision4 months ago
Determined Problem-Solver4 months ago
How to Get Product Iteration Right in HealthcareNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Announces Nine More TrumpRx Participants
2
Eli Lilly Announces Topline Results From Phase III Trial Studying Oral GLP-1 Therapy Orforglipron
3
BioMarin Reaches $4.8 Billion Definitive Agreement to Acquire Amicus Therapeutics
4
Novo Nordisk Submits NDA to FDA for CagriSema
5
